A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients.

PURPOSE: Poor prognosis of patients with muscle-invasive bladder cancer (BC) that often metastasizes drives the need for discovery of molecular determinants of BC progression. Chondroitin sulfate proteoglycans, including CD44, regulate cancer progression; however, the identity of a chondroitinase (C...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cancer Res
Päätekijät: Lokeshwar, Vinata B., Morera, Daley S., Hasanali, Sarrah L., Yates, Travis J., Hupe, Marie C., Knapp, Judith S., Lokeshwar, Soum D., Wang, Jiaojiao, Hennig, Martin, Baskar, Rohitha, Escudero, Diogo O., Racine, Ronny R., Dhir, Neetika, Jordan, Andre R., Hoye, Kelly, Azih, Ijeoma, Manoharan, Murugesan, Klaassen, Zachary, Kavuri, Sravankumar, Lopez, Luis E., Ghosh, Santu, Lokeshwar, Bal L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334064/
https://ncbi.nlm.nih.gov/pubmed/32094233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2912
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia